Table of Contents: Preface:
Chapter 1.-Regulation of Synthesis and Metabolism of the Amyloid Precursor Protein by Extracellular Signals; pp. 1-26
(Barbara E. Slack, Boston University School of Medicine, and Richard J. Wurtman, Massachusetts Institute of Technology);
Chapter 2.-Modelling Alzheimer’s Disease: What can we Learn from Mice?; pp. 27-56
(Christopher Janus and Judith Wilson, Mayo Clinic Jacksonville);
Chapter 3.-Cerebral Inflammation and Alzheimer's Disease; pp. 57-96 (Parvathy Sarvanapavan, and Greer M. Murphy, Jr., Stanford School of Medicine);
Chapter 4.-Myelin Breakdown Trajectories and Risk Factors for Age-Related Cognitive Decline and Alzheimer’s Disease; pp. 97-107
(George Bartzokis, David Geffen School of Medicine at UCLA);
Chapter 5.-Alzheimer Disease: A Deregulated Cell Cycle Disease;
pp. 109-122
(Teresa A. Evans, Xiongwei Zhu, Hyoung-gon Lee, et al., Wuhan University, China );
Chapter 6.-Cholesterol, Statins and Alzheimer’s Disease: Past, Present and Future; pp. 123-135
(Benjamin Wolozin, Wesleyan University in Middletown, U.S.A.);
Chapter 7.-Cholesterol Oxidation and b-Amyloid: Perspectives on Alzheimer’s disease and Therapy; pp. 137-174
(Thomas J. Nelson, The Blanchette Rockefeller Neurosciences Institute);
Chapter 8.-ABAD: Mitochondrial Target for Aâ-Mediated Cellular Perturbation in Alzheimer Disease; pp. 175-189
(Shirley ShiDu Yan, Xi Chen, and Hao Wu, Columbia University U.S.A.);
Chapter 9.-The Role of Sex Steroids in Alzheimer’s Disease and Age-Related Cognitive Decline; pp. 191-226
(A. Yesufu, S. Bandelow and E. Hogervorst, Human Sciences Loughborough University,
U.K.);
Chapter 10.-Estrogen Therapy for Preventing Alzheimer's Disease: Therapeutic Strategies to Address Hormone Therapy Challenge for the Brain; pp. 227-249
(Liqin Zhao and Roberta Diaz Brinton, University of Southern California);
Chapter 11.-Behavioral and Psychological Symptoms of Alzheimer’s Disease; pp. 251-272
(Rajesh R. Tampi and Christopher H. van Dyck, Yale School of Medicine);
Chapter 12.-Memantine for Alzheimer’s Disease; pp. 273-306
(Abhilash K. Desai and George T. Grossberg, St. Louis University Health Science Center School of Medicine);
Chapter 13.-Enoxaparin as a Therapeutic Agent for Alzheimer’s Disease; pp. 307-326
(Luigi Bergamaschini, University of Milan, Italy, and Maria Grazia De Simon, Mario Negri Institute,Italy);
Chapter 14.-Head Injury and Dementia; pp. 327-355
(Kurt A. Jellinger, Vienna University School of Medicine, Austria);
Index |